Arteriovenous malformations (AVM) are congenital malformations of the cerebral
vasculature resulting in pathological shunting of blood through dilated arteries and veins …

Introduction Data describing safety and tolerability of anticoagulation and antiplatelet
therapy in hereditary hemorrhagic telangiectasia (HHT), the second-most-common inherited …

Somatic activating MAP2K1 mutations in endothelial cells (ECs) cause extracranial
arteriovenous malformation (AVM). We previously reported the generation of a mouse line …

Extracranial arteriovenous malformations (AVMs) are regarded as rare diseases and are
prone to complications such as pain, bleeding, relentless growth, and high volume of …

Background Antithrombotic therapy (anticoagulation and antiplatelet therapy) is frequently
needed in patients with hereditary hemorrhagic telangiectasia (HHT); however, data …

Optimal management of complex vascular anomalies aims to not only treat acute issues,
such as infection or effusion, but also prevent potential future complications and improve …

Overgrowth syndromes, diagnosis and management : Current Opinion in Pediatrics
Overgrowth syndromes, diagnosis and management : Current Opinion in Pediatrics Log in or …

Arteriovenous malformations are high‐flow congenital vascular malformations that are
characterized by abnormal connections between arteries and veins across an abnormal …

Pulmonary arteriovenous malformations (PAVMs), particularly where feeding artery/arteries
to PAVMs≥ 3 mm can be treated with embolization. The treatment for hypoxemia resulting …

Hereditary hemorrhagic telangiectasia (HHT) is the second-most common inherited
bleeding disorder (BD) worldwide and remains without approved therapies. HHT causes …